Crossmark

A comparative study of folate receptor-targeted doxorubicin delivery systems: Dosing regimens and therapeutic index

Crossref DOI link: https://doi.org/10.1016/j.jconrel.2015.04.009

Published Print: 2015-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Scomparin, Anna

Salmaso, Stefano

Eldar-Boock, Anat

Ben-Shushan, Dikla

Ferber, Shiran

Tiram, Galia

Shmeeda, Hilary

Landa-Rouben, Natalie

Leor, Jonathan

Caliceti, Paolo

Gabizon, Alberto

Satchi-Fainaro, Ronit
Funding

Funding for this research was provided by:

European Research Council (617445)

Israel Science Foundation (918/14)

Israeli National Nanotechnology Initiative (INNI)

Focal Technology Area (FTA) program: Nanomedicine for Personalized Theranostics

Leona M. and Harry B. Helmsley Nanotechnology Research Fund

Israel Cancer Research Fund (RCDA-09-717)

Ministry of Science, Technology and Space of Israel (0601165111)

Ministry of Foreign Affairs of Italy (CUP C94G13000080005)
License Information

Text and Data Mining valid from 2015-06-01
More Information

This article is maintained by: Elsevier

Article Title: A comparative study of folate receptor-targeted doxorubicin delivery systems: Dosing regimens and therapeutic index

Journal Title: Journal of Controlled Release

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jconrel.2015.04.009

Content Type: article

Copyright: Copyright © 2015 Elsevier B.V. All rights reserved.